Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis

10.1007/s12325-020-01395-x

Saved in:

Bibliographic Details
Main Authors:	Huang, Shang-Yi, Yoon, Sung-Soo, Shimizu, Kazuyuki, Chng, Wee Joo, Chang, Cheng-Shyong, Wong, Raymond Siu-Ming, Gao, Seasea, Wang, Yang, Gordon, Steve W, Glennane, Anthony, Min, Chang-Ki
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Article
Language:	English
Published:	SPRINGER 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Asian patients Denosumab Multiple myeloma Skeletal-related event Zoledronic acid SKELETAL-RELATED EVENTS PLACEBO-CONTROLLED TRIAL POSTMENOPAUSAL WOMEN PREVENTION CANCER
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/229004
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-229004
record_format	dspace
spelling	sg-nus-scholar.10635-2290042024-11-09T01:52:16Z Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis Huang, Shang-Yi Yoon, Sung-Soo Shimizu, Kazuyuki Chng, Wee Joo Chang, Cheng-Shyong Wong, Raymond Siu-Ming Gao, Seasea Wang, Yang Gordon, Steve W Glennane, Anthony Min, Chang-Ki DEAN'S OFFICE (MEDICINE) Prof Wee Joo Chng Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Asian patients Denosumab Multiple myeloma Skeletal-related event Zoledronic acid SKELETAL-RELATED EVENTS PLACEBO-CONTROLLED TRIAL POSTMENOPAUSAL WOMEN PREVENTION CANCER 10.1007/s12325-020-01395-x ADVANCES IN THERAPY 37 7 3404-3416 2022-07-21T06:32:41Z 2022-07-21T06:32:41Z 2020-06-10 2022-07-17T12:10:21Z Article Huang, Shang-Yi, Yoon, Sung-Soo, Shimizu, Kazuyuki, Chng, Wee Joo, Chang, Cheng-Shyong, Wong, Raymond Siu-Ming, Gao, Seasea, Wang, Yang, Gordon, Steve W, Glennane, Anthony, Min, Chang-Ki (2020-06-10). Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis. ADVANCES IN THERAPY 37 (7) : 3404-3416. ScholarBank@NUS Repository. https://doi.org/10.1007/s12325-020-01395-x 0741238X 18658652 https://scholarbank.nus.edu.sg/handle/10635/229004 en SPRINGER Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Asian patients Denosumab Multiple myeloma Skeletal-related event Zoledronic acid SKELETAL-RELATED EVENTS PLACEBO-CONTROLLED TRIAL POSTMENOPAUSAL WOMEN PREVENTION CANCER
spellingShingle	Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Asian patients Denosumab Multiple myeloma Skeletal-related event Zoledronic acid SKELETAL-RELATED EVENTS PLACEBO-CONTROLLED TRIAL POSTMENOPAUSAL WOMEN PREVENTION CANCER Huang, Shang-Yi Yoon, Sung-Soo Shimizu, Kazuyuki Chng, Wee Joo Chang, Cheng-Shyong Wong, Raymond Siu-Ming Gao, Seasea Wang, Yang Gordon, Steve W Glennane, Anthony Min, Chang-Ki Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
description	10.1007/s12325-020-01395-x
author2	DEAN'S OFFICE (MEDICINE)
author_facet	DEAN'S OFFICE (MEDICINE) Huang, Shang-Yi Yoon, Sung-Soo Shimizu, Kazuyuki Chng, Wee Joo Chang, Cheng-Shyong Wong, Raymond Siu-Ming Gao, Seasea Wang, Yang Gordon, Steve W Glennane, Anthony Min, Chang-Ki
format	Article
author	Huang, Shang-Yi Yoon, Sung-Soo Shimizu, Kazuyuki Chng, Wee Joo Chang, Cheng-Shyong Wong, Raymond Siu-Ming Gao, Seasea Wang, Yang Gordon, Steve W Glennane, Anthony Min, Chang-Ki
author_sort	Huang, Shang-Yi
title	Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
title_short	Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
title_full	Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
title_fullStr	Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
title_full_unstemmed	Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis
title_sort	denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, randomized controlled phase 3 study-asian subgroup analysis
publisher	SPRINGER
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/229004
_version_	1821201210722484224

Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis

Similar Items